-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Prime Medicine, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2020 to Q2 2025.
- Prime Medicine, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2025 was $0.000.
- Prime Medicine, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2025 was $0.000.
- Prime Medicine, Inc. annual Income Tax Expense (Benefit) for 2024 was $0.000.
- Prime Medicine, Inc. annual Income Tax Expense (Benefit) for 2023 was -$279K, a 70.6% increase from 2022.
- Prime Medicine, Inc. annual Income Tax Expense (Benefit) for 2022 was -$948K, a 95.1% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)